AVELEZA
Live / Allowed — Publication / registration review complete (as of 18 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99323843
- Mark type
- Stylized text
- Filed
- 06 Aug 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of endocrine, metabolic, and hormonal related diseases and disorders
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 12 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Dec 2025 — NON-FINAL ACTION E-MAILED
- 20 Dec 2025 — NON-FINAL ACTION WRITTEN
- 19 Dec 2025 — ASSIGNED TO EXAMINER